ID   ARGI1_RAT               Reviewed;         323 AA.
AC   P07824; Q5BK93;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 2.
DT   24-JUL-2024, entry version 202.
DE   RecName: Full=Arginase-1;
DE            EC=3.5.3.1 {ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:16266687};
DE   AltName: Full=Liver-type arginase;
DE   AltName: Full=Type I arginase;
GN   Name=Arg1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3571256; DOI=10.1016/s0021-9258(18)45565-2;
RA   Kawamoto S., Amaya Y., Murakami K., Tokunaga F., Iwanaga S., Kobayashi K.,
RA   Saheki T., Kimura S., Mori M.;
RT   "Complete nucleotide sequence of cDNA and deduced amino acid sequence of
RT   rat liver arginase.";
RL   J. Biol. Chem. 262:6280-6283(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=2892837; DOI=10.1016/s0021-9258(18)69197-5;
RA   Ohtake A., Takiguchi M., Shigeto Y., Amaya Y., Kawamoto S., Mori M.;
RT   "Structural organization of the gene for rat liver-type arginase.";
RL   J. Biol. Chem. 263:2245-2249(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   MUTAGENESIS OF GLY-235.
RX   PubMed=11883902; DOI=10.1006/abbi.2001.2720;
RA   Lavulo L.T., Emig F.A., Ash D.E.;
RT   "Functional consequences of the G235R mutation in liver arginase leading to
RT   hyperargininemia.";
RL   Arch. Biochem. Biophys. 399:49-55(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62 AND THR-281, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH MANGANESE.
RX   PubMed=8849731; DOI=10.1038/383554a0;
RA   Kanyo Z.F., Scolnick L.R., Ash D.E., Christianson D.W.;
RT   "Structure of a unique binuclear manganese cluster in arginase.";
RL   Nature 383:554-557(1996).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) IN COMPLEX WITH MANGANESE.
RX   PubMed=9265637; DOI=10.1021/bi970800v;
RA   Scolnick L.R., Kanyo Z.F., Cavalli R.C., Ash D.E., Christianson D.W.;
RT   "Altering the binuclear manganese cluster of arginase diminishes
RT   thermostability and catalytic function.";
RL   Biochemistry 36:10558-10565(1997).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH MANGANESE, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=10542097; DOI=10.1038/14929;
RA   Cox J.D., Kim N.N., Traish A.M., Christianson D.W.;
RT   "Arginase-boronic acid complex highlights a physiological role in erectile
RT   function.";
RL   Nat. Struct. Biol. 6:1043-1047(1999).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 6-319 OF MUTANTS ASN-101; GLU-101;
RP   ASN-128; GLU-128; ALA-232; CYS-232 AND GLU-234 IN COMPLEXES WITH MANGANESE
RP   IONS, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF HIS-101;
RP   ASP-128; ASP-232 AND ASP-234, AND CATALYTIC ACTIVITY.
RX   PubMed=12820884; DOI=10.1021/bi030074y;
RA   Cama E., Emig F.A., Ash D.E., Christianson D.W.;
RT   "Structural and functional importance of first-shell metal ligands in the
RT   binuclear manganese cluster of arginase I.";
RL   Biochemistry 42:7748-7758(2003).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 6-319 IN COMPLEX WITH MANGANESE
RP   IONS AND THE SYNTHETIC INHIBITOR (S)-2-AMINO-7-OXOHEPTANOIC ACID.
RX   PubMed=15315440; DOI=10.1021/ja047788w;
RA   Shin H., Cama E., Christianson D.W.;
RT   "Design of amino acid aldehydes as transition-state analogue inhibitors of
RT   arginase.";
RL   J. Am. Chem. Soc. 126:10278-10284(2004).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 6-319 OF MUTANTS ALA-141; ASN-141;
RP   ASP-141 AND CYS-141 IN COMPLEX WITH MANGANESE IONS, COFACTOR, MUTAGENESIS
RP   OF HIS-141, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=16266687; DOI=10.1016/j.abb.2005.09.009;
RA   Colleluori D.M., Reczkowski R.S., Emig F.A., Cama E., Cox J.D.,
RA   Scolnick L.R., Compher K., Jude K., Han S., Viola R.E., Christianson D.W.,
RA   Ash D.E.;
RT   "Probing the role of the hyper-reactive histidine residue of arginase.";
RL   Arch. Biochem. Biophys. 444:15-26(2005).
CC   -!- FUNCTION: Key element of the urea cycle converting L-arginine to urea
CC       and L-ornithine, which is further metabolized into metabolites proline
CC       and polyamides that drive collagen synthesis and bioenergetic pathways
CC       critical for cell proliferation, respectively; the urea cycle takes
CC       place primarily in the liver and, to a lesser extent, in the kidneys.
CC       {ECO:0000305}.
CC   -!- FUNCTION: Functions in L-arginine homeostasis in nonhepatic tissues
CC       characterized by the competition between nitric oxide synthase (NOS)
CC       and arginase for the available intracellular substrate arginine.
CC       Arginine metabolism is a critical regulator of innate and adaptive
CC       immune responses. Involved in an antimicrobial effector pathway in
CC       polymorphonuclear granulocytes (PMN). Upon PMN cell death is liberated
CC       from the phagolysosome and depletes arginine in the microenvironment
CC       leading to suppressed T cell and natural killer (NK) cell proliferation
CC       and cytokine secretion (By similarity). In group 2 innate lymphoid
CC       cells (ILC2s) promotes acute type 2 inflammation in the lung and is
CC       involved in optimal ILC2 proliferation but not survival. Plays a role
CC       in the immune response of alternatively activated or M2 macrophages in
CC       processes such as wound healing and tissue regeneration, immune defense
CC       against multicellular pathogens and parasites, and immune suppression
CC       and allergic inflammation; the regulatory outcome seems to be organ
CC       specific. In tumor-infiltrating dendritic cells (DCs) and myeloid-
CC       derived suppressor cells (MDSCs) plays a role in suppression of T cell-
CC       mediated antitumor immunity. {ECO:0000250|UniProtKB:P05089,
CC       ECO:0000250|UniProtKB:Q61176}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-arginine = L-ornithine + urea; Xref=Rhea:RHEA:20569,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16199, ChEBI:CHEBI:32682,
CC         ChEBI:CHEBI:46911; EC=3.5.3.1; Evidence={ECO:0000269|PubMed:12820884,
CC         ECO:0000269|PubMed:16266687};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00742,
CC         ECO:0000269|PubMed:10542097, ECO:0000269|PubMed:12820884,
CC         ECO:0000269|PubMed:15315440, ECO:0000269|PubMed:16266687,
CC         ECO:0000269|PubMed:8849731, ECO:0000269|PubMed:9265637};
CC       Note=Binds 2 manganese ions per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00742, ECO:0000269|PubMed:10542097,
CC       ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
CC       ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
CC       ECO:0000269|PubMed:9265637};
CC   -!- ACTIVITY REGULATION: Inactivated by diethyl pyrocarbonate (DEPC).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.4 mM for arginine {ECO:0000269|PubMed:12820884,
CC         ECO:0000269|PubMed:16266687};
CC   -!- PATHWAY: Nitrogen metabolism; urea cycle; L-ornithine and urea from L-
CC       arginine: step 1/1. {ECO:0000250|UniProtKB:P05089}.
CC   -!- SUBUNIT: Homotrimer (PubMed:15315440, PubMed:16266687). Interacts with
CC       CMTM6 (By similarity). {ECO:0000250|UniProtKB:P05089,
CC       ECO:0000269|PubMed:15315440, ECO:0000269|PubMed:16266687}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P05089}.
CC       Cytoplasmic granule {ECO:0000250|UniProtKB:P05089}.
CC   -!- TISSUE SPECIFICITY: Detected in liver (at protein level).
CC       {ECO:0000269|PubMed:16266687}.
CC   -!- INDUCTION: By arginine or homoarginine.
CC   -!- SIMILARITY: Belongs to the arginase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00742}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02720; AAA40761.1; -; mRNA.
DR   EMBL; M17931; AAA40760.1; -; Genomic_DNA.
DR   EMBL; M17924; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17925; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17926; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17927; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17928; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17929; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; M17930; AAA40760.1; JOINED; Genomic_DNA.
DR   EMBL; BC091158; AAH91158.1; -; mRNA.
DR   PIR; A26702; A26702.
DR   RefSeq; NP_058830.2; NM_017134.3.
DR   PDB; 1D3V; X-ray; 1.70 A; A/B=1-323.
DR   PDB; 1HQ5; X-ray; 2.30 A; A/B=1-323.
DR   PDB; 1HQF; X-ray; 2.90 A; A/B/C=1-323.
DR   PDB; 1HQG; X-ray; 2.00 A; A/B/C=1-323.
DR   PDB; 1HQH; X-ray; 2.80 A; A/B/C=1-323.
DR   PDB; 1HQX; X-ray; 3.00 A; A/B/C=1-323.
DR   PDB; 1P8M; X-ray; 2.84 A; A/B/C=6-319.
DR   PDB; 1P8N; X-ray; 2.90 A; A/B/C=6-319.
DR   PDB; 1P8O; X-ray; 2.96 A; A/B/C=6-319.
DR   PDB; 1P8P; X-ray; 2.50 A; A/B/C=6-319.
DR   PDB; 1P8Q; X-ray; 2.95 A; A/B/C=6-319.
DR   PDB; 1P8R; X-ray; 2.50 A; A/B=6-313.
DR   PDB; 1P8S; X-ray; 3.20 A; A/B/C=6-319.
DR   PDB; 1R1O; X-ray; 2.80 A; A/B/C=1-323.
DR   PDB; 1RLA; X-ray; 2.10 A; A/B/C=1-323.
DR   PDB; 1T4P; X-ray; 2.60 A; A/B/C=6-319.
DR   PDB; 1T4R; X-ray; 2.60 A; A/B/C=6-319.
DR   PDB; 1T4S; X-ray; 2.80 A; A/B/C=6-319.
DR   PDB; 1T4T; X-ray; 2.20 A; A/B/C=6-319.
DR   PDB; 1T5F; X-ray; 2.20 A; A/B/C=6-319.
DR   PDB; 1T5G; X-ray; 2.40 A; A/B/C=6-319.
DR   PDB; 1TA1; X-ray; 2.50 A; A/B/C=6-319.
DR   PDB; 1TBH; X-ray; 2.70 A; A/B/C=6-319.
DR   PDB; 1TBJ; X-ray; 2.80 A; A/B/C=6-319.
DR   PDB; 1TBL; X-ray; 3.10 A; A/B/C=6-319.
DR   PDB; 1ZPE; X-ray; 1.70 A; A/B/C=6-319.
DR   PDB; 1ZPG; X-ray; 1.90 A; A/B/C=6-319.
DR   PDB; 2RLA; X-ray; 3.00 A; A/B/C=1-323.
DR   PDB; 3E8Q; X-ray; 2.90 A; A/B/C=1-323.
DR   PDB; 3E8Z; X-ray; 2.00 A; A/B/C=1-323.
DR   PDB; 3E9B; X-ray; 2.15 A; A/B/C=1-323.
DR   PDB; 3RLA; X-ray; 2.54 A; A/B/C=1-323.
DR   PDB; 4RLA; X-ray; 2.94 A; A/B/C=1-323.
DR   PDB; 5RLA; X-ray; 2.74 A; A/B/C=1-323.
DR   PDBsum; 1D3V; -.
DR   PDBsum; 1HQ5; -.
DR   PDBsum; 1HQF; -.
DR   PDBsum; 1HQG; -.
DR   PDBsum; 1HQH; -.
DR   PDBsum; 1HQX; -.
DR   PDBsum; 1P8M; -.
DR   PDBsum; 1P8N; -.
DR   PDBsum; 1P8O; -.
DR   PDBsum; 1P8P; -.
DR   PDBsum; 1P8Q; -.
DR   PDBsum; 1P8R; -.
DR   PDBsum; 1P8S; -.
DR   PDBsum; 1R1O; -.
DR   PDBsum; 1RLA; -.
DR   PDBsum; 1T4P; -.
DR   PDBsum; 1T4R; -.
DR   PDBsum; 1T4S; -.
DR   PDBsum; 1T4T; -.
DR   PDBsum; 1T5F; -.
DR   PDBsum; 1T5G; -.
DR   PDBsum; 1TA1; -.
DR   PDBsum; 1TBH; -.
DR   PDBsum; 1TBJ; -.
DR   PDBsum; 1TBL; -.
DR   PDBsum; 1ZPE; -.
DR   PDBsum; 1ZPG; -.
DR   PDBsum; 2RLA; -.
DR   PDBsum; 3E8Q; -.
DR   PDBsum; 3E8Z; -.
DR   PDBsum; 3E9B; -.
DR   PDBsum; 3RLA; -.
DR   PDBsum; 4RLA; -.
DR   PDBsum; 5RLA; -.
DR   AlphaFoldDB; P07824; -.
DR   SMR; P07824; -.
DR   BioGRID; 247899; 3.
DR   IntAct; P07824; 1.
DR   STRING; 10116.ENSRNOP00000017911; -.
DR   BindingDB; P07824; -.
DR   ChEMBL; CHEMBL3232699; -.
DR   CarbonylDB; P07824; -.
DR   iPTMnet; P07824; -.
DR   PhosphoSitePlus; P07824; -.
DR   PaxDb; 10116-ENSRNOP00000017911; -.
DR   GeneID; 29221; -.
DR   KEGG; rno:29221; -.
DR   AGR; RGD:2150; -.
DR   CTD; 383; -.
DR   RGD; 2150; Arg1.
DR   VEuPathDB; HostDB:ENSRNOG00000013304; -.
DR   eggNOG; KOG2965; Eukaryota.
DR   HOGENOM; CLU_039478_6_1_1; -.
DR   InParanoid; P07824; -.
DR   OrthoDB; 161483at2759; -.
DR   PhylomeDB; P07824; -.
DR   TreeFam; TF300034; -.
DR   BRENDA; 3.5.3.1; 5301.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-70635; Urea cycle.
DR   SABIO-RK; P07824; -.
DR   UniPathway; UPA00158; UER00270.
DR   EvolutionaryTrace; P07824; -.
DR   PRO; PR:P07824; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000013304; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0004053; F:arginase activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0030145; F:manganese ion binding; IDA:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0019547; P:arginine catabolic process to ornithine; IDA:RGD.
DR   GO; GO:0006525; P:arginine metabolic process; IDA:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0032964; P:collagen biosynthetic process; IMP:RGD.
DR   GO; GO:0042832; P:defense response to protozoan; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0060056; P:mammary gland involution; IEP:RGD.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEP:RGD.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; ISO:RGD.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:2000552; P:negative regulation of T-helper 2 cell cytokine production; ISO:RGD.
DR   GO; GO:0060336; P:negative regulation of type II interferon-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:RGD.
DR   GO; GO:0070965; P:positive regulation of neutrophil mediated killing of fungus; ISO:RGD.
DR   GO; GO:1905541; P:regulation of L-arginine import across plasma membrane; IDA:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0009635; P:response to herbicide; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0010042; P:response to manganese ion; IEP:RGD.
DR   GO; GO:0051597; P:response to methylmercury; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0010269; P:response to selenium ion; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0033197; P:response to vitamin E; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   GO; GO:0000050; P:urea cycle; IDA:RGD.
DR   CDD; cd11587; Arginase-like; 1.
DR   Gene3D; 3.40.800.10; Ureohydrolase domain; 1.
DR   InterPro; IPR014033; Arginase.
DR   InterPro; IPR006035; Ureohydrolase.
DR   InterPro; IPR023696; Ureohydrolase_dom_sf.
DR   InterPro; IPR020855; Ureohydrolase_Mn_BS.
DR   NCBIfam; TIGR01229; rocF_arginase; 1.
DR   PANTHER; PTHR43782; ARGINASE; 1.
DR   PANTHER; PTHR43782:SF2; ARGINASE-1; 1.
DR   Pfam; PF00491; Arginase; 1.
DR   PIRSF; PIRSF036979; Arginase; 1.
DR   PRINTS; PR00116; ARGINASE.
DR   SUPFAM; SSF52768; Arginase/deacetylase; 1.
DR   PROSITE; PS01053; ARGINASE_1; 1.
DR   PROSITE; PS51409; ARGINASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Arginine metabolism; Cytoplasm; Hydrolase;
KW   Immunity; Innate immunity; Manganese; Metal-binding; Phosphoprotein;
KW   Reference proteome; Urea cycle.
FT   CHAIN           1..323
FT                   /note="Arginase-1"
FT                   /id="PRO_0000173697"
FT   REGION          1..27
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         101
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0007744|PDB:1D3V, ECO:0007744|PDB:1HQ5,
FT                   ECO:0007744|PDB:1HQF, ECO:0007744|PDB:1HQG,
FT                   ECO:0007744|PDB:1HQH, ECO:0007744|PDB:1HQX,
FT                   ECO:0007744|PDB:1P8M, ECO:0007744|PDB:1P8N,
FT                   ECO:0007744|PDB:1P8O, ECO:0007744|PDB:1P8Q,
FT                   ECO:0007744|PDB:1P8S, ECO:0007744|PDB:1R1O,
FT                   ECO:0007744|PDB:1RLA, ECO:0007744|PDB:1T4P,
FT                   ECO:0007744|PDB:1T4R, ECO:0007744|PDB:1T4S,
FT                   ECO:0007744|PDB:1T4T, ECO:0007744|PDB:1T5F,
FT                   ECO:0007744|PDB:1T5G, ECO:0007744|PDB:1TA1,
FT                   ECO:0007744|PDB:1TBH, ECO:0007744|PDB:1TBJ,
FT                   ECO:0007744|PDB:1TBL, ECO:0007744|PDB:1ZPE,
FT                   ECO:0007744|PDB:1ZPG, ECO:0007744|PDB:3E8Q,
FT                   ECO:0007744|PDB:3E8Z, ECO:0007744|PDB:3E9B"
FT   BINDING         124
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0000269|PubMed:9265637, ECO:0007744|PDB:1D3V,
FT                   ECO:0007744|PDB:1HQ5, ECO:0007744|PDB:1HQF,
FT                   ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1HQX, ECO:0007744|PDB:1P8M,
FT                   ECO:0007744|PDB:1P8N, ECO:0007744|PDB:1P8O,
FT                   ECO:0007744|PDB:1P8P, ECO:0007744|PDB:1P8Q,
FT                   ECO:0007744|PDB:1P8R, ECO:0007744|PDB:1P8S,
FT                   ECO:0007744|PDB:1R1O, ECO:0007744|PDB:1RLA,
FT                   ECO:0007744|PDB:1T4P, ECO:0007744|PDB:1T4R,
FT                   ECO:0007744|PDB:1T4S, ECO:0007744|PDB:1T4T,
FT                   ECO:0007744|PDB:1T5F, ECO:0007744|PDB:1T5G,
FT                   ECO:0007744|PDB:1TA1, ECO:0007744|PDB:1TBH,
FT                   ECO:0007744|PDB:1TBJ, ECO:0007744|PDB:1TBL,
FT                   ECO:0007744|PDB:1ZPE, ECO:0007744|PDB:1ZPG,
FT                   ECO:0007744|PDB:3E8Q, ECO:0007744|PDB:3E8Z,
FT                   ECO:0007744|PDB:3E9B, ECO:0007744|PDB:3RLA"
FT   BINDING         124
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0000269|PubMed:9265637, ECO:0007744|PDB:1D3V,
FT                   ECO:0007744|PDB:1HQ5, ECO:0007744|PDB:1HQF,
FT                   ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1HQX, ECO:0007744|PDB:1P8M,
FT                   ECO:0007744|PDB:1P8O, ECO:0007744|PDB:1P8P,
FT                   ECO:0007744|PDB:1P8Q, ECO:0007744|PDB:1P8R,
FT                   ECO:0007744|PDB:1P8S, ECO:0007744|PDB:1R1O,
FT                   ECO:0007744|PDB:1RLA, ECO:0007744|PDB:1T4P,
FT                   ECO:0007744|PDB:1T4R, ECO:0007744|PDB:1T4S,
FT                   ECO:0007744|PDB:1T4T, ECO:0007744|PDB:1T5F,
FT                   ECO:0007744|PDB:1T5G, ECO:0007744|PDB:1TA1,
FT                   ECO:0007744|PDB:1TBH, ECO:0007744|PDB:1TBJ,
FT                   ECO:0007744|PDB:1TBL, ECO:0007744|PDB:1ZPE,
FT                   ECO:0007744|PDB:1ZPG, ECO:0007744|PDB:2RLA,
FT                   ECO:0007744|PDB:3E8Q, ECO:0007744|PDB:3E8Z,
FT                   ECO:0007744|PDB:3E9B, ECO:0007744|PDB:3RLA,
FT                   ECO:0007744|PDB:4RLA, ECO:0007744|PDB:5RLA"
FT   BINDING         126..130
FT                   /ligand="substrate"
FT                   /evidence="ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1T5G"
FT   BINDING         126
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0000269|PubMed:9265637, ECO:0007744|PDB:1D3V,
FT                   ECO:0007744|PDB:1HQ5, ECO:0007744|PDB:1HQF,
FT                   ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1HQX, ECO:0007744|PDB:1P8M,
FT                   ECO:0007744|PDB:1P8O, ECO:0007744|PDB:1P8P,
FT                   ECO:0007744|PDB:1P8Q, ECO:0007744|PDB:1P8R,
FT                   ECO:0007744|PDB:1P8S, ECO:0007744|PDB:1R1O,
FT                   ECO:0007744|PDB:1RLA, ECO:0007744|PDB:1T4P,
FT                   ECO:0007744|PDB:1T4R, ECO:0007744|PDB:1T4S,
FT                   ECO:0007744|PDB:1T4T, ECO:0007744|PDB:1T5F,
FT                   ECO:0007744|PDB:1T5G, ECO:0007744|PDB:1TA1,
FT                   ECO:0007744|PDB:1TBH, ECO:0007744|PDB:1TBJ,
FT                   ECO:0007744|PDB:1TBL, ECO:0007744|PDB:1ZPE,
FT                   ECO:0007744|PDB:1ZPG, ECO:0007744|PDB:2RLA,
FT                   ECO:0007744|PDB:3E8Q, ECO:0007744|PDB:3E8Z,
FT                   ECO:0007744|PDB:3E9B, ECO:0007744|PDB:3RLA,
FT                   ECO:0007744|PDB:4RLA, ECO:0007744|PDB:5RLA"
FT   BINDING         128
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0000269|PubMed:9265637, ECO:0007744|PDB:1D3V,
FT                   ECO:0007744|PDB:1HQ5, ECO:0007744|PDB:1HQF,
FT                   ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1HQX, ECO:0007744|PDB:1P8N,
FT                   ECO:0007744|PDB:1P8P, ECO:0007744|PDB:1P8Q,
FT                   ECO:0007744|PDB:1P8R, ECO:0007744|PDB:1P8S,
FT                   ECO:0007744|PDB:1R1O, ECO:0007744|PDB:1RLA,
FT                   ECO:0007744|PDB:1T4P, ECO:0007744|PDB:1T4R,
FT                   ECO:0007744|PDB:1T4S, ECO:0007744|PDB:1T4T,
FT                   ECO:0007744|PDB:1T5F, ECO:0007744|PDB:1T5G,
FT                   ECO:0007744|PDB:1TA1, ECO:0007744|PDB:1TBH,
FT                   ECO:0007744|PDB:1TBJ, ECO:0007744|PDB:1TBL,
FT                   ECO:0007744|PDB:1ZPE, ECO:0007744|PDB:1ZPG,
FT                   ECO:0007744|PDB:3E8Q, ECO:0007744|PDB:3E8Z,
FT                   ECO:0007744|PDB:3E9B, ECO:0007744|PDB:3RLA"
FT   BINDING         137..139
FT                   /ligand="substrate"
FT                   /evidence="ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH"
FT   BINDING         183
FT                   /ligand="substrate"
FT                   /evidence="ECO:0007744|PDB:1T5G"
FT   BINDING         232
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0000269|PubMed:9265637, ECO:0007744|PDB:1D3V,
FT                   ECO:0007744|PDB:1HQ5, ECO:0007744|PDB:1HQF,
FT                   ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1HQX, ECO:0007744|PDB:1P8M,
FT                   ECO:0007744|PDB:1P8O, ECO:0007744|PDB:1P8P,
FT                   ECO:0007744|PDB:1P8Q, ECO:0007744|PDB:1P8R,
FT                   ECO:0007744|PDB:1R1O, ECO:0007744|PDB:1RLA,
FT                   ECO:0007744|PDB:1T4P, ECO:0007744|PDB:1T4R,
FT                   ECO:0007744|PDB:1T4S, ECO:0007744|PDB:1T4T,
FT                   ECO:0007744|PDB:1T5F, ECO:0007744|PDB:1T5G,
FT                   ECO:0007744|PDB:1TA1, ECO:0007744|PDB:1TBH,
FT                   ECO:0007744|PDB:1TBJ, ECO:0007744|PDB:1TBL,
FT                   ECO:0007744|PDB:1ZPE, ECO:0007744|PDB:1ZPG,
FT                   ECO:0007744|PDB:3E8Q, ECO:0007744|PDB:3E8Z,
FT                   ECO:0007744|PDB:3E9B, ECO:0007744|PDB:3RLA"
FT   BINDING         232
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0000269|PubMed:9265637, ECO:0007744|PDB:1D3V,
FT                   ECO:0007744|PDB:1HQ5, ECO:0007744|PDB:1HQF,
FT                   ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1HQX, ECO:0007744|PDB:1P8M,
FT                   ECO:0007744|PDB:1P8O, ECO:0007744|PDB:1P8P,
FT                   ECO:0007744|PDB:1P8Q, ECO:0007744|PDB:1P8R,
FT                   ECO:0007744|PDB:1R1O, ECO:0007744|PDB:1RLA,
FT                   ECO:0007744|PDB:1T4P, ECO:0007744|PDB:1T4R,
FT                   ECO:0007744|PDB:1T4S, ECO:0007744|PDB:1T4T,
FT                   ECO:0007744|PDB:1T5F, ECO:0007744|PDB:1T5G,
FT                   ECO:0007744|PDB:1TA1, ECO:0007744|PDB:1TBH,
FT                   ECO:0007744|PDB:1TBJ, ECO:0007744|PDB:1TBL,
FT                   ECO:0007744|PDB:1ZPE, ECO:0007744|PDB:1ZPG,
FT                   ECO:0007744|PDB:2RLA, ECO:0007744|PDB:3E8Q,
FT                   ECO:0007744|PDB:3E8Z, ECO:0007744|PDB:3E9B,
FT                   ECO:0007744|PDB:3RLA, ECO:0007744|PDB:4RLA,
FT                   ECO:0007744|PDB:5RLA"
FT   BINDING         234
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:10542097,
FT                   ECO:0000269|PubMed:12820884, ECO:0000269|PubMed:15315440,
FT                   ECO:0000269|PubMed:16266687, ECO:0000269|PubMed:8849731,
FT                   ECO:0000269|PubMed:9265637, ECO:0007744|PDB:1D3V,
FT                   ECO:0007744|PDB:1HQ5, ECO:0007744|PDB:1HQF,
FT                   ECO:0007744|PDB:1HQG, ECO:0007744|PDB:1HQH,
FT                   ECO:0007744|PDB:1HQX, ECO:0007744|PDB:1P8M,
FT                   ECO:0007744|PDB:1P8O, ECO:0007744|PDB:1P8P,
FT                   ECO:0007744|PDB:1P8R, ECO:0007744|PDB:1P8S,
FT                   ECO:0007744|PDB:1R1O, ECO:0007744|PDB:1RLA,
FT                   ECO:0007744|PDB:1T4P, ECO:0007744|PDB:1T4R,
FT                   ECO:0007744|PDB:1T4S, ECO:0007744|PDB:1T4T,
FT                   ECO:0007744|PDB:1T5F, ECO:0007744|PDB:1T5G,
FT                   ECO:0007744|PDB:1TA1, ECO:0007744|PDB:1TBH,
FT                   ECO:0007744|PDB:1TBJ, ECO:0007744|PDB:1TBL,
FT                   ECO:0007744|PDB:1ZPE, ECO:0007744|PDB:1ZPG,
FT                   ECO:0007744|PDB:2RLA, ECO:0007744|PDB:3E8Q,
FT                   ECO:0007744|PDB:3E8Z, ECO:0007744|PDB:3E9B,
FT                   ECO:0007744|PDB:3RLA, ECO:0007744|PDB:4RLA,
FT                   ECO:0007744|PDB:5RLA"
FT   BINDING         246
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P53608"
FT   BINDING         277
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P78540"
FT   MOD_RES         17
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61176"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61176"
FT   MOD_RES         75
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61176"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05089"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05089"
FT   MOD_RES         281
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         101
FT                   /note="H->E: Reduced catalytic activity. No effect on
FT                   manganese binding."
FT                   /evidence="ECO:0000269|PubMed:12820884"
FT   MUTAGEN         128
FT                   /note="D->E,N: Reduced manganese binding and strongly
FT                   reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:12820884"
FT   MUTAGEN         141
FT                   /note="H->A,C,D: Strongly reduced catalytic activity. Minor
FT                   effect on affinity for arginine."
FT                   /evidence="ECO:0000269|PubMed:16266687"
FT   MUTAGEN         141
FT                   /note="H->N: Reduced affinity for arginine and reduced
FT                   catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16266687"
FT   MUTAGEN         232
FT                   /note="D->A: Loss of one manganese ion and strongly reduced
FT                   catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:12820884"
FT   MUTAGEN         232
FT                   /note="D->C: Reduced manganese binding and strongly reduced
FT                   catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:12820884"
FT   MUTAGEN         234
FT                   /note="D->A,E,H: Reduced manganese binding and strongly
FT                   reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:12820884"
FT   MUTAGEN         235
FT                   /note="G->A: 56% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:11883902"
FT   MUTAGEN         235
FT                   /note="G->R: Loss of manganese-binding and activity."
FT                   /evidence="ECO:0000269|PubMed:11883902"
FT   CONFLICT        298
FT                   /note="A -> P (in Ref. 1; AAA40761/AAA40760)"
FT                   /evidence="ECO:0000305"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:1ZPE"
FT   HELIX           22..26
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           27..33
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           36..40
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          43..45
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          64..66
FT                   /evidence="ECO:0007829|PDB:5RLA"
FT   STRAND          67..69
FT                   /evidence="ECO:0007829|PDB:1ZPE"
FT   HELIX           70..89
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          93..97
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           101..103
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           104..114
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          119..126
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   TURN            132..134
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          136..138
FT                   /evidence="ECO:0007829|PDB:1TBH"
FT   HELIX           140..142
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           144..148
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           150..152
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          153..156
FT                   /evidence="ECO:0007829|PDB:1P8O"
FT   TURN            160..164
FT                   /evidence="ECO:0007829|PDB:1HQH"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          174..179
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           184..193
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          196..199
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           200..206
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           208..220
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          221..223
FT                   /evidence="ECO:0007829|PDB:3E9B"
FT   STRAND          227..232
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           233..235
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   TURN            238..240
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           254..267
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   STRAND          270..276
FT                   /evidence="ECO:0007829|PDB:1D3V"
FT   HELIX           280..282
FT                   /evidence="ECO:0007829|PDB:1ZPE"
FT   STRAND          283..285
FT                   /evidence="ECO:0007829|PDB:1P8R"
FT   HELIX           286..303
FT                   /evidence="ECO:0007829|PDB:1D3V"
SQ   SEQUENCE   323 AA;  34973 MW;  5A92CB0931F9A053 CRC64;
     MSSKPKPIEI IGAPFSKGQP RGGVEKGPAA LRKAGLVEKL KETEYNVRDH GDLAFVDVPN
     DSPFQIVKNP RSVGKANEQL AAVVAETQKN GTISVVLGGD HSMAIGSISG HARVHPDLCV
     IWVDAHTDIN TPLTTSSGNL HGQPVAFLLK ELKGKFPDVP GFSWVTPCIS AKDIVYIGLR
     DVDPGEHYII KTLGIKYFSM TEVDKLGIGK VMEETFSYLL GRKKRPIHLS FDVDGLDPVF
     TPATGTPVVG GLSYREGLYI TEEIYKTGLL SGLDIMEVNP TLGKTPEEVT RTVNTAVALT
     LSCFGTKREG NHKPETDYLK PPK
//
